Novel immune potentiators and delivery technologies for next generation vaccines
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York [u.a.]
Springer
2013
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Klappentext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV042238031 | ||
003 | DE-604 | ||
005 | 20150123 | ||
007 | t | ||
008 | 141213s2013 ad|| |||| 00||| eng d | ||
020 | |a 9781461453796 |c Hardcover |9 978-1-4614-5379-6 | ||
035 | |a (OCoLC)840572059 | ||
035 | |a (DE-599)BVBBV042238031 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | 4 | |a 616.079 |2 23 |
084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
245 | 1 | 0 | |a Novel immune potentiators and delivery technologies for next generation vaccines |c Manmohan Singh, ed. |
264 | 1 | |a New York [u.a.] |b Springer |c 2013 | |
300 | |a X, 369 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Medizin | |
650 | 4 | |a Medicine | |
650 | 4 | |a Immunology | |
650 | 4 | |a Microbiology | |
650 | 4 | |a Vaccines | |
650 | 4 | |a Pharmaceutical technology | |
650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Forschung |0 (DE-588)4017894-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 0 | 1 | |a Forschung |0 (DE-588)4017894-8 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Singh, Manmohan |d 1964- |e Sonstige |0 (DE-588)142086886 |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-4614-5380-2 |
856 | 4 | 2 | |m Digitalisierung UB Regensburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m Digitalisierung UB Regensburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
999 | |a oai:aleph.bib-bvb.de:BVB01-027676217 |
Datensatz im Suchindex
_version_ | 1804152776455880704 |
---|---|
adam_text | Contents
Section
I Novel Immune Potentiators and Delivery Systems
for Enhancing Vaccine Potency
1
TLR7/8 Agonists as Vaccine Adjuvants
............................................... 3
Mark
A. Tomai
and John P.
Vasi lakos
2
Preclinical and Clinical Development of Synthetic iNKT-Cell
Glycolipid Agonists as Vaccine Adjuvants
........................................... 19
Josianne
Nitcheu, Sandrine Crabe,
Gwyn Davies, and Vincent
Serra
3
Mu
cosai
Vaccination: Opportunities and Challenges
......................... 65
Olga Borges
and
Gerrit
В
orchard
4
Oral Vaccination: Attenuated and Gene-Based
.................................. 81
Wendy Peters,
Ciaran
D.
Scałlan,
and
Sean
N.
Tucker
Section
Π
Design and Development of Next Generation Vaccines
5
Development of Biophysical Assays to Better Understand
Adjuvanted Vaccine
Formulation
Potency and Stability
................... 107
James Chesko, Thomas Vedvick, and Steve Reed
6
High Throughput Screening for Stabilizers of Vaccine Antigens
...... 119
C. Russell Middaugh, David B. Volkin, and Sangeeta B. Joshi
7
Exploring Novel Analytical Tools to Improve Characterization
of Vaccine Formulations
........................................................................ 145
Michele Pallaoro
8
bnnaunobioengjiieering Approaches Towards Combinatorial
Delivery of Immune-Modulators and Antigens
................................... 161
Ankur Singh, Pallab Pradhan, and Krishnendu Roy
Vii
viii
Contents
Section
HI Novel Delivery Technologies for Vaccines
9
Current Status of Electroporation Technologies
for Vaccine Delivery
............................................................................... 185
Claire F. Evans and Drew
Harmaman
10
M
і
ero
needles for IntradermaJ Vaccination: Lmmunopotentiation
and Formulation Aspects
....................................................................... 217
Alexander K. Andrianov
11
MicroCor® Transdermal Delivery System: A Safe,
Efficient, and Convenient
Transdermal
System
for Vaccine Administration
................................................................... 233
Parminder
Singh, Guohua Chen, and Wade Worsham
12
Mimopath™-Based Vaccine Delivery
.................................................. 245
Kees
Leenhouts
Section IV Novel Particulate Delivery Systems for Vaccines and Adjuvants
13
NanoBio™ Nanoemulsion for Mucosal Vaccine Delivery
.................. 269
Tarek Hamouda, Jakub
Simon, Ali Fattom,
and James Baker
14
Influenza Virosomes as Antigen Delivery System
............................... 287
Christian
Moser
and Mario Amacker
15
Matrix
M
Adjuvant Technology
........................................................... 309
Karm Lövgren Bengtsson
Section V Safety Assessment of Next Generation Vaccines
16
S
trategies for the NoncJinical Safety Assessment of Vaccines
............ 3 23
Jayanthi J. Wolf, Lisa M.
Plitnick,
and
Danuta
J. Herzyk
17
Safety Challenges Facing Next Generation Vaccines
and the Role for
Biomarkers
.................................................................. 351
S. Sohail
Ahmed, Ernesto
Oviedo-
Orta, and
Jeffrey
Ulm er
Index
................................................................................................................. 365
Manmohan Singh Editor
Novel Immune Potentiators and
for Next Generation Vaccines
Development of new-generation vaccines is now more challenging than ever, as
identifying^ purifying and evaluating vaccine antigens is a complex undertaking- Most
importantly, once the relevant antigens have been identified, key focus then shifts to
the development of suitable delivery systems and formulations to achieve maximum
in vivo potency with minimum potential side effects. These novel formulations
—
many
of which will be nanoparticulates
—
can deliver the antigens to the desired site, to
the relevant antigen presenting cells, and prevent systemic exposure of the immune
potentiators. This book outlines all the critical steps that need to be considered for
successful development of various types of nanoparticulate delivery systems for vaccine
antigens. These contributions from leading experts
ід
the area of
vaccine
formulation
äad
delivery systems tie in what is the most current status,
Hicluidiag
clioicaJ evaluations
with these novel vaccine technologies.
|
any_adam_object | 1 |
author_GND | (DE-588)142086886 |
building | Verbundindex |
bvnumber | BV042238031 |
classification_rvk | XD 3300 |
ctrlnum | (OCoLC)840572059 (DE-599)BVBBV042238031 |
dewey-full | 616.079 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.079 |
dewey-search | 616.079 |
dewey-sort | 3616.079 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01990nam a2200457 c 4500</leader><controlfield tag="001">BV042238031</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150123 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">141213s2013 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461453796</subfield><subfield code="c">Hardcover</subfield><subfield code="9">978-1-4614-5379-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)840572059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042238031</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel immune potentiators and delivery technologies for next generation vaccines</subfield><subfield code="c">Manmohan Singh, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 369 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschung</subfield><subfield code="0">(DE-588)4017894-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Forschung</subfield><subfield code="0">(DE-588)4017894-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Manmohan</subfield><subfield code="d">1964-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)142086886</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-4614-5380-2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027676217</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV042238031 |
illustrated | Illustrated |
indexdate | 2024-07-10T01:16:05Z |
institution | BVB |
isbn | 9781461453796 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027676217 |
oclc_num | 840572059 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | X, 369 S. Ill., graph. Darst. |
publishDate | 2013 |
publishDateSearch | 2013 |
publishDateSort | 2013 |
publisher | Springer |
record_format | marc |
spelling | Novel immune potentiators and delivery technologies for next generation vaccines Manmohan Singh, ed. New York [u.a.] Springer 2013 X, 369 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Medizin Medicine Immunology Microbiology Vaccines Pharmaceutical technology Impfstoff (DE-588)4026655-2 gnd rswk-swf Forschung (DE-588)4017894-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Impfstoff (DE-588)4026655-2 s Forschung (DE-588)4017894-8 s DE-604 Singh, Manmohan 1964- Sonstige (DE-588)142086886 oth Erscheint auch als Online-Ausgabe 978-1-4614-5380-2 Digitalisierung UB Regensburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
spellingShingle | Novel immune potentiators and delivery technologies for next generation vaccines Medizin Medicine Immunology Microbiology Vaccines Pharmaceutical technology Impfstoff (DE-588)4026655-2 gnd Forschung (DE-588)4017894-8 gnd |
subject_GND | (DE-588)4026655-2 (DE-588)4017894-8 (DE-588)4143413-4 |
title | Novel immune potentiators and delivery technologies for next generation vaccines |
title_auth | Novel immune potentiators and delivery technologies for next generation vaccines |
title_exact_search | Novel immune potentiators and delivery technologies for next generation vaccines |
title_full | Novel immune potentiators and delivery technologies for next generation vaccines Manmohan Singh, ed. |
title_fullStr | Novel immune potentiators and delivery technologies for next generation vaccines Manmohan Singh, ed. |
title_full_unstemmed | Novel immune potentiators and delivery technologies for next generation vaccines Manmohan Singh, ed. |
title_short | Novel immune potentiators and delivery technologies for next generation vaccines |
title_sort | novel immune potentiators and delivery technologies for next generation vaccines |
topic | Medizin Medicine Immunology Microbiology Vaccines Pharmaceutical technology Impfstoff (DE-588)4026655-2 gnd Forschung (DE-588)4017894-8 gnd |
topic_facet | Medizin Medicine Immunology Microbiology Vaccines Pharmaceutical technology Impfstoff Forschung Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027676217&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT singhmanmohan novelimmunepotentiatorsanddeliverytechnologiesfornextgenerationvaccines |